Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS AUGUST ISSUE PUBLISHED
  • AUGUST 2020 Issue has been successfully launched on 1 August 2020.

Abstract

RECENT ADVANCES IN NASAL FORMULATIONS AND DEVICES USED IN PULMONARY DRUG DELIVERY

T. Praveen Kumar*1, M. Indira Vani1, D. Yamini1, P. Narayana Raju1,G. Nagarjuna Reddy1

Department of Pharmaceutics, K. L. R Pharmacy College,Paloncha, Khammam, Andhra Pradesh, India.

ABSTRACT

Pulmonary drug delivery has gained tremendous scientific interest in recent years and has progressed within the context of treatment for lung diseases. Lung is an attractive environment for bio molecules, which are highly susceptible to enzymatic degradation in the gastrointestinal tract as well as hepatic degradation. Pulmonary route is a non-invasive administration for systemic delivery of therapeutic agents (mainly peptides and proteins). Lungs provide a large absorptive surface area but extremely thin (0.1 μm – 0.2 μm) absorptive mucosal membrane and good blood supply. Intra tracheal administration is a first approach in lung drug delivery in vivo. In inhalation therapy most common devices used were nebulizer, Metered dose inhaler (MDI), and Dry powder inhaler (DPI). Pulmonary drug delivery is used for management of COPD and Asthma. Last few years techniques and new drug delivery devices intended to deliver drugs into the lungs have been widely developed. Pulmonary drug delivery can also be used to treat Diabetes, angina pectoris, cancer, bone disorders, tuberculosis, migraine acute lung injury and others. Liposomes, nano and micro particles, cyclodextrins, micro emulsions, micelles, suspensions, or solutions are all examples of the pharmaceutical drug carriers that have been successfully used to target drugs into lungs. This review discusses the approaches and devices required to be administer drug into the lungs.

Keywords: Asthma, Lungs, Nanoparticles, Nebulizer, Non-invasive, Pulmonary drug


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More